Rigel Pharmaceuticals | RIGL - Kapitalizacja Rynkowa





Kapitalizacja Rynkowa Zmiana Data
Agenus USD 1.66B 1.55B 2026-03
Amgen USD 176.25B 24.32B 2025-12
Anika Therapeutics USD 210M 71M 2026-03
Arrowhead Research USD 9.02B 4.25B 2025-12
AstraZeneca USD 220.14B 68B 2026-03
BioMarin Pharmaceutical USD 11.76B 348M 2026-03
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Celldex Therapeutics USD 1.81B 87M 2025-12
Daiichi Sankyo JPY 6.34T 62.51B 2025-12
Eli Lilly USD 1.02T 293.84B 2025-12
Halozyme Therapeutics USD 7.91B 664M 2025-12
Heron Therapeutics USD 133M 105M 2026-03
Ionis Pharmaceuticals USD 12.81B 2.39B 2025-12
MacroGenics USD 192M 90M 2026-03
Neurocrine Biosciences USD 14.14B 218M 2025-12
Pfizer USD 153.96B 12.4B 2026-03
Regeneron Pharmaceuticals USD 81.12B 21.53B 2025-12
Ultragenyx Pharmaceutical USD 2.22B 680M 2025-12
Veracyte USD 3.33B 627M 2025-12